Overview
- The C-TRACT randomized trial, published Monday in the New England Journal of Medicine, found fewer patients had severe post-thrombotic syndrome at six months with stenting than with standard care alone.
- Among 225 patients across 29 U.S. sites, 40% in the stent group still had severe disease at six months versus 61% with standard treatment.
- Patients who received stents reported better daily function, scoring 14 points higher on a 100-point quality-of-life scale than those without stents.
- Researchers presented the results at the Society of Interventional Radiology meeting in Toronto and said the findings show this condition is treatable in many patients.
- The procedure reopens blocked pelvic veins with a small-incision stent placement that takes about two to three hours, addressing the flow obstruction that blood thinners and compression do not fix.